Global promotion of herbal medicine: India's opportunity

Current Science

Volumn 86, Issue 1, 2004, Pages 37-41

  Dubey, N K ^a   Kumar, Rajesh ^a   Tripathi, Pramila ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4444279847     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Gijtenbeek, J. M. M., Vanden Bent, M. J. and Vecht, C. J., Cyclosporine neurotoxicity. J. Neurol., 1999, 246, 339-346.
2. Johnson, W. C. and William, O. W., Warfarin toxicity. J. Vasc. Surg., 2002, 35, 413-421.
3. Rajshekharan, P. E., Herbal medicine. In World of Science, Employment News, 21-27 November 2002, p. 3.
4. WHO, General guidelines for methodologies on research and evaluation of traditional medicine, World Health Organization, Geneva, 2000.
5. Khatoon, S., Mehrotra, S., Shome, U. and Mehrotra, B. N., Analysis of commercial 'Ratanjot' by TLC fluorescence fingerprinting. Int. J. Pharmacol., 1993, 31, 269-277.
6. Anon, The Useful Plants of India, PID, CSIR, New Delhi, 1996, p. 918.
7. Gupta, Akshey, K., Vats, S. K. and Lal Brij, How cheap can a medicinal plant species be ? Curr. Sci., 1998, 74, 565-566.
8. Prajapati, N. D., Purohit, S. S., Sharma, A. K. and Kumar Tarun, A Hand Book of Medicinal Plants, Agrobios (India), Jodhpur, 2003, p. 153.
9. Horie, Y., Yamazaki, M., Itokawa, H. and Kinoshita, H., On the toxigenic fungi contaminating herbal drugs as raw materials in pharmaceutical industries. Trans. Mycol. Soc. Jpn., 1979, 23, 435-447.
10. Narita, N. et al., Aflatoxin potential of Aspergillus flavus isolates from Indonesian herbal drugs. Proc. Jpn. Assoc. Mycotoxin Colloq., 1980, 27, 21-26.
11. Roy, A. K. and Chaurasia, H. K., Aflatoxin problems in some medicinal plants under storage. Int. J. Crude Drug Res., 1989, 27, 156-160.
12. Roy, A. K., Mycological problems of crude herbal drugs - overview and challenges. Indian Phytopathol., 2003, 4, 1-13.
13. Roy, A. K., Threat to medicinal plants and drugs by fungi. J. Indian Bot. Soc., 1989, 68, 149-153.
14. Pandey, G. S. and Chunekar, K. C., Bhavprakasha Nighantu (Indian Materia Medica), Chaukhambha Bharati Academy, Varanasi, 2002, pp. 342; 454-455.
15. Shah, B. K., Drugs. News Views, 1997, 4, 7.
16. Singh, S. K., Proceedings of Global Promotion of Tradition Medicine in View of Institute - Industry Relationship, 2002, Faculty of Ayurveda, Banaras Hindu University, pp. 112-115.
17. Duke, J. A. and Bogenschutz-Godwin, M. J., Natural Products from Plants, CRC Press, Boca Raton, FL, USA, 1999, pp. 183-205.
18. Whitley, D., CNS drugs. In Trease and Evans Pharmacognosy (ed. Evans, W. C.), W.B. Saunders, Edinburgh, London, 2002, p. 52.
19. Beckstrom-Sternberg, S. M. and Duke, J. A., Spices, Herbs and Edible Fungi, Elsevier Publication, 1994, pp. 210-213.
20. Miaorong, P. and Jing, L., Proceedings of the 40th Annual Conference on Chinese Medicine, Beijing University, 1996, pp. 28-30.
21. Evans, W. C., Trease and Evans Pharmacognosy, W.B. Saunders, Edinburgh, London, 2002, p. 72.
22. Handa S. S., Medicinal plants based drug industry and emerging plant drugs. Curr. Res. Med. Aromat. Plants, 1992, 14, 233-262.
23. Horonok, I., Cultivation and Processing of Medicinal Plants, Wiley and Sons, Chickester, UK, 1992, pp. 221-235.
24. Das, B., Padmarao, S. and Kashinatham, A., Taxol content in the storage samples of the needles of Himalayan Taxus baccata and their extracts. Planta Med., 1998, 64, 96.
25. Ghosh, S. P., Medicinal and aromatic plants. Indian Hortic., 1998, 43, 25-27.